Increased Risk of Hypothyroidism in People with Asthma: Evidence from a Real-World Population-Based Study

被引:20
作者
Huang, Shih-Cheng [1 ]
Gau, Shuo-Yan [2 ]
Huang, Jing-Yang [1 ,3 ]
Wu, Wen-Jun [1 ,4 ]
Wei, James Cheng-Chung [1 ,5 ,6 ]
机构
[1] Chung Shan Med Univ, Inst Med, Taichung 40201, Taiwan
[2] Chung Shan Med Univ, Sch Med, Taichung 40201, Taiwan
[3] Chung Shan Med Univ Hosp, Ctr Hlth Data Sci, Taichung 40201, Taiwan
[4] Chung Shan Med Univ, Sch Med, Dept Microbiol & Immunol, Taichung 40201, Taiwan
[5] Chung Shan Med Univ Hosp, Dept Allergy Immunol & Rheumatol, Taichung 40201, Taiwan
[6] China Med Univ, Grad Inst Integrated Med, Taichung 40402, Taiwan
关键词
hypothyroidism; asthma; real-world study; cohort study; DISEASE; ASSOCIATION; TH17; STRATEGIES; MECHANISMS;
D O I
10.3390/jcm11102776
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
Background: Non-T2 asthma and hypothyroidism share several inflammatory mechanisms in common. However, large-scale, real-world studies evaluating the association between asthma and hypothyroidism are lacking. The objective of this study was to evaluate the risk for asthma patients of developing hypothyroidism. Methods: In the retrospective cohort study, people with asthma were recruited from the Longitudinal Health Insurance Database in Taiwan. After excluding ineligible patients with a previous history of hypothyroidism, 1:1 propensity matching was conducted to select a non-asthma control group. Based on the multivariate Cox regression model, the adjusted hazard ratio of asthma patients developing hypothyroidism was calculated. Results: In total, 95,321 asthma patients were selected as the asthma group and the same amount of people without asthma were selected as the control group. The incidence levels of new-onset hypothyroidism in asthma and non-asthma groups were 8.13 and 6.83 per 100,000 people per year, respectively. Compared with the non-asthma group, the adjusted hazard ratio of the asthma group developing hypothyroidism was 1.217 (95% confidence interval, 1.091-1.357). Conclusions: We found having asthma to be associated with an increased risk of hypothyroidism. Clinicians should be concerned regarding the endocrinological and inflammatory interaction between the two diseases while caring for people with asthma.
引用
收藏
页数:10
相关论文
共 39 条
[1]  
Abd El-Aziz M.F., 2010, THYROID SCI, V5, pCLS1
[2]   Autoimmune Hypothyroidism As a Predictor of Morality in Chronic Hypersensitivity Pneumonitis [J].
Adegunsoye, Ayodeji ;
Oldham, Justin M. ;
Husain, Aliya N. ;
Chen, Lena ;
Hsu, Scully ;
Montner, Steven ;
Chung, Jonathan H. ;
Vij, Rekha ;
Noth, Imre ;
Strek, Mary E. .
FRONTIERS IN MEDICINE, 2017, 4
[3]   Increased serum IL-17 is an independent risk factor for severe asthma [J].
Agache, Ioana ;
Ciobanu, Cristina ;
Agache, Costel ;
Anghel, Mariana .
RESPIRATORY MEDICINE, 2010, 104 (08) :1131-1137
[4]   Thyroid Dysfunction and Diabetes Mellitus: Two Closely Associated Disorders [J].
Biondi, Bernadette ;
Kahaly, George J. ;
Robertson, R. Paul .
ENDOCRINE REVIEWS, 2019, 40 (03) :789-824
[5]   Nonrespiratory Comorbidities in Asthma [J].
Cardet, Juan Carlos ;
Bulkhi, Adeeb A. ;
Lockey, Richard F. .
JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY-IN PRACTICE, 2021, 9 (11) :3887-3897
[6]   Celiac Disease and Hypothyroidism [J].
Collins, Dan ;
Wilcox, Rebecca ;
Nathan, Muriel ;
Zubarik, Richard .
AMERICAN JOURNAL OF MEDICINE, 2012, 125 (03) :278-282
[7]   Circulating Th17 cytokine levels are altered in Hashimoto's thyroiditis [J].
Degertekin, Ceyla Konca ;
Yilmaz, Banu Aktas ;
Toruner, Fusun Balos ;
Kalkanci, Ayse ;
Iyidir, Ozlem Turhan ;
Fidan, Isil ;
Yesilyurt, Emine ;
Cakir, Nuri ;
Kustimur, Semra ;
Arslan, Metin .
CYTOKINE, 2016, 80 :13-17
[8]  
Esfahanian Fatemeh, 2017, Indian J Endocrinol Metab, V21, P551, DOI 10.4103/ijem.IJEM_412_16
[9]   Type 2 inflammation in asthma - present in most, absent in many [J].
Fahy, John V. .
NATURE REVIEWS IMMUNOLOGY, 2015, 15 (01) :57-65
[10]   Acute asthma, prognosis, and treatment [J].
Fergeson, Jennifer E. ;
Patel, Shiven S. ;
Lockey, Richard F. .
JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY, 2017, 139 (02) :438-447